STERIS plc (STE)

Market Cap	19.74B
Revenue (ttm)	5.41B
Net Income (ttm)	566.84M
Shares Out	98.81M
EPS (ttm)	5.70
PE Ratio	35.21
Forward PE	21.25
Dividend	$2.08 (1.04%)
Ex-Dividend Date	Feb 22, 2024

Volume	43,068
Open	201.73
Previous Close	200.81
Day's Range	199.40 - 202.44
52-Week Range	180.54 - 254.00
Beta	0.79
Analysts	Buy
Price Target	242.67 (+21.65%)
Earnings Date	May 8, 2024

About STE

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lig...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jun 1, 1992
• Employees: 17,100
• Stock Exchange: NYSE
• Ticker Symbol: STE

Financial Performance

In 2022, STERIS's revenue was $4.96 billion, an increase of 8.13% compared to the previous year's $4.59 billion. Earnings were $107.03 million, a decrease of -56.12%.

Analyst Forecast

According to 7 analysts, the average rating for STE stock is "Buy." The 12-month stock price forecast is $242.67, which is an increase of 21.65% from the latest price.

Price Target

$242.67

(21.65% upside)

Analyst Consensus: Buy